Latest period
$95.40M
YoY change
+5.9%
5Y CAGR
-0.3%
Peak year (2018)
$96.50M
Latest annual
$94.80M
Stock-Based Compensation history chart for CME Group (CME) from 2000 to 2025
Latest: $94.80M
Stock-Based Compensation growth chart for CME Group (CME) from 2000 to 2025
Latest: +5.9%
Stock-Based Compensation history table for CME Group (CME) from 2000 to 2025
| 2025 | $94.80M | +5.9% | +$5.30M | ||
| 2024 | $89.50M | +8.0% | +$6.60M | ||
| 2023 | $82.90M | -1.7% | −$1.40M | ||
| 2022 | $84.30M | +12.1% | +$9.10M | ||
| 2021 | $75.20M | -21.7% | −$20.80M | ||
| 2020 | $96.00M | +31.3% | +$22.90M | ||
| 2019 | $73.10M | -24.2% | −$23.40M | ||
| 2018 | $96.50M | +66.4% | +$38.50M | ||
| 2017 | $58.00M | -12.4% | −$8.20M | ||
| 2016 | $66.20M | +8.9% | +$5.40M | ||
| 2015 | $60.80M | +10.9% | +$6.00M | ||
| 2014 | $54.80M | +0.7% | +$400.00K | ||
| 2013 | $54.40M | -11.4% | −$7.00M | ||
| 2012 | $61.40M | +19.7% | +$10.10M | ||
| 2011 | $51.30M | +25.4% | +$10.40M | ||
| 2010 | $40.90M | +22.5% | +$7.50M | ||
| 2009 | $33.40M | — | +$33.40M | ||
| 2008 | $0.00 | -100.0% | −$22.85M | ||
| 2007 | $22.85M | +39.7% | +$6.49M | ||
| 2006 | $16.36M | — | +$16.36M | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | — |
- 2025$94.80M+5.9%
- 2024$89.50M+8.0%
- 2023$82.90M-1.7%
- 2022$84.30M+12.1%
- 2021$75.20M-21.7%
- 2020$96.00M+31.3%
- 2019$73.10M-24.2%
- 2018$96.50M+66.4%
- 2017$58.00M-12.4%
- 2016$66.20M+8.9%
- 2015$60.80M+10.9%
- 2014$54.80M+0.7%
- 2013$54.40M-11.4%
- 2012$61.40M+19.7%
- 2011$51.30M+25.4%
- 2010$40.90M+22.5%
- 2009$33.40M—
- 2008$0.00-100.0%
- 2007$22.85M+39.7%
- 2006$16.36M—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
Stock-Based Compensation values are taken from CME Group's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at CME Group (CME)
Stock-Based Compensation for CME Group (CME): headline value $95.40M · YoY +5.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
CME Group (CME) most recent annual stock-based compensation stands at $94.80M (2025) – grew 5.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, CME Group stock-based compensation compounded at -0.3% per year, with a net decline across the window.
Across the available history, stock-based compensation reached its high of $96.50M in 2018 and its low of $0.00 in 2000.
CME Group Stock-Based Compensation by Year
CME Group Stock-Based Compensation 2025: $94.80M
CME Group posted stock-based compensation of $94.80M in 2025, grew 5.9% from 2024.
CME Group Stock-Based Compensation 2024: $89.50M
In 2024, CME Group reported stock-based compensation of $89.50M, grew 8.0% from 2023.
CME Group Stock-Based Compensation 2023: $82.90M
CME Group stock-based compensation in 2023 was $82.90M, edged down 1.7% below 2022.
CME Group Stock-Based Compensation 2022: $84.30M
2022's stock-based compensation for CME Group came in at $84.30M, grew 12.1% from 2021.
CME Group Stock-Based Compensation 2021: $75.20M
CME Group stock-based compensation in 2021 was $75.20M.
See more financial history for CME Group (CME).
Sector peers by Stock-Based Compensation
Financial Services peers of CME Group (CME), ranked by their latest stock-based compensation
| $4.00B | |
| $3.44B | |
| $1.93B | |
| $897.00M | |
| $597.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $4.00B
- $3.44B
- $1.93B
- $897.00M
- $597.00M
- $0.00
- $0.00
Frequently asked questions
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation